Press releases

To stay up to date with our development, sign up for a subscription.

Subscribe

Sedana Medical’s Nomination Committee established

Regulatory

According to the principles for the appointment of the Nomination Committee in Sedana Medical AB (publ), the Nomination Committee for the annual general meeting 2023 shall be composed of members appointed by the three largest shareholders as of Septe…

Sedana Medical presents at ESICM

Non-regulatory

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the company will hold a scientific symposium during ESICM Lives 2022, the annual congress of the European Society of Intensive Care Medicine. Additional data on inhaled sedation wil…

Sedana Medical’s products receive MDR certification

Non-regulatory

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the company has received Medical Device Regulation (MDR) certification, which secures EU market access for Sedaconda® ACD under the new MDR regulation, well ahead of the deadline in…

Bulletin from the annual general meeting in Sedana Medical AB (publ)

Regulatory

Today, the annual general meeting of Sedana Medical AB (publ) (SEDANA: FN Stockholm) was held. In order to counteract the spreading of the corona virus, the general meeting was held only through advance voting (so-called postal voting) in accordance…

Notice of Annual General Meeting in Sedana Medical AB (publ)

Regulatory

The shareholders in Sedana Medical AB (publ), reg. no. 556670-2519, are hereby given notice to attend the annual general meeting to be held Wednesday, 11 May 2022. In order to counteract the spreading of the corona virus, the board of directors of th…

Sedana Medical presents post hoc analysis at ISICEM

Non-regulatory

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that a post hoc analysis on the Sedaconda study will be presented as a poster at the world’s largest conference for intensive care and emergency medicine, ISICEM, in Brussels on March 22…

Sedana Medical’s first Sedaconda (isoflurane) shipments

Non-regulatory

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the first bottles of Sedaconda (isoflurane) have been delivered to customers. The first sales were made in the company’s largest market Germany.

Sedana Medical’s Sedaconda ACD recommended by NICE

Non-regulatory

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the National Institute for Health and Care Excellence (NICE) has issued positive guidance recommending Sedaconda ACD as a cost-saving option for delivering inhaled sedation in inten…

Sedana Medical appoints Johan Spetz as new CFO

Regulatory

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces the appointment of Johan Spetz as the company’s new Chief Financial Officer (CFO). Johan Spetz will take office no later than April 4, 2022, succeeding Susanne Andersson who will leave h…